Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer
Libo Wang, Zaoqu Liu, Ruopeng Liang, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 60
Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options
Zaoqu Liu, Hui Xu, Siyuan Weng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma
Yuyan Xu, Wei Liao, Qiong Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
A Novel Lactate Metabolism-Related Gene Signature for Predicting Clinical Outcome and Tumor Microenvironment in Hepatocellular Carcinoma
Yue Li, Huanye Mo, Shengli Wu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 32
ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
Xiaoxi Ouyang, Longxian Lv, Yalei Zhao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 28
Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma
Zaoqu Liu, Long Liu, Chunguang Guo, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108340-108340
Closed Access | Times Cited: 30
Computational Recognition and Clinical Verification of TGF-β-Derived miRNA Signature With Potential Implications in Prognosis and Immunotherapy of Intrahepatic Cholangiocarcinoma
Zaoqu Liu, Siyuan Weng, Hui Xu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26
Immune Landscape Refines the Classification of Colorectal Cancer With Heterogeneous Prognosis, Tumor Microenvironment and Distinct Sensitivity to Frontline Therapies
Zaoqu Liu, Yaxin Guo, Xiuxiu Yang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 19
Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer
Chunguang Guo, Zaoqu Liu, Yin Yu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 18
Natural compounds as regulators of miRNAs: exploring a new avenue for treating colorectal cancer
Ahmed S. Doghish, Sherif S Abdel Mageed, Osama A. Mohammed, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
CD8+ T cell activation in endometrial cancer: prognostic implications and potential for personalized therapy
Haotong Guan, Qian Xiong, Jun Xiong, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Clinical Significance and Immune Landscape of a Pyroptosis-Derived LncRNA Signature for Glioblastoma
Zhe Xing, Zaoqu Liu, Xudong Fu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 15
A Systems Biology Approach to Identify Novel Biomarkers in Progression from Crohn’s Disease to Colorectal Cancer
Niloofar Shokrollah, Pouria Samadi, Akram Jalali, et al.
Asian Pacific Journal of Cancer Prevention (2023) Vol. 24, Iss. 6, pp. 1993-2001
Open Access | Times Cited: 9
Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma
Pingfei Tang, Weiming Qu, Taoli Wang, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 19
Identification of a Pyroptosis-Related Prognostic Signature Combined With Experiments in Hepatocellular Carcinoma
Huihui Li, Li Tang, Xiaohua Zhang
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 14
Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
Wen Tong, Guangyu Wang, Liuyang Zhu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 13
Multi-omics landscape and clinical significance of a SMAD4-driven immune signature: Implications for risk stratification and frontline therapies in pancreatic cancer
Libo Wang, Zaoqu Liu, Rongtao Zhu, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 1154-1167
Open Access | Times Cited: 13
Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer
Siyuan Weng, Minghao Li, Jinhai Deng, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma
Dong Cai, Zhibo Zhao, Jie‐Jun Hu, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 12
Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer
Rui Shi, Haojia Li, Sitian Wei, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Development and validation of a novel prognostic lncRNA signature based on the APOBEC3 family genes in gastric cancer
Qi Jia, Wenxuan Wu, Jing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e28307-e28307
Open Access | Times Cited: 2
Construction and validation of a nomogram model for predicting the overall survival of colorectal cancer patients
Peiyuan Guo, Hu xuhua, Guo Ganlin, et al.
BMC Surgery (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Identification of the Pyroptosis-Related Gene Signature for Overall Survival Prediction in Patients With Hepatocellular Carcinoma
Shuang Liu, Ruonan Shao, Xiaoyun Bu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Activation of the chemokine receptor 3 pathway leads to a better response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma
Wenqin Feng, Anqi Lin, Le Sun, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 9
The Function, Role and Process of DDX58 in Heart Failure and Human Cancers
Ping Yu, Peng Liang, Shifeng Pang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top